Ocular TherapeutixTM Announces Closing of Public Offering of Common Stock
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL) today announced the closing of its underwritten public offering of 7,475,000 shares of its common stock at a public offering price of $5.00 per share. The shares of common stock issued and sold in the offering at the closing include 975,000 shares issued upon the exercise in full by the underwriter of its option to purchase additional shares at the public offering price, less underwriting discounts and commissions. The of